secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 75328 grounded facts newest July 10, 2026, 5:10 PM ET RSS · JSON

Showing 3401–3450 of 33040

Departed

Christopher Stanley

Director
FNMA · FEDERAL NATIONAL MORTGAGE ASSOCIATION FANNIE MAE
Effective
2025-03-18
Filed
March 19, 2025, 7:59 PM ET
On March 18, 2025, Christopher Stanley notified us of his resignation from Fannie’s Mae Board of Directors, effective as of that date.
Departed

Edward P. Loomis, Jr.

member of the Board of Directors
CBAN · COLONY BANKCORP INC
Filed
March 19, 2025, 7:59 PM ET
On March 17, 2025, Edward P. Loomis, Jr., member of the Board of Directors of Colony Bankcorp, Inc. (the “Company”) and Colony Bank (the “Bank”), provided notice of his decision not to stand for reelection at the Company’s 2025 Annual Meeting of Shareholders (the “2025 Annual Meeting”).
Departed

Frances P. Grieb

Director
FIBK · FIRST INTERSTATE BANCSYSTEM INC
Filed
March 19, 2025, 7:59 PM ET
Ms. Frances P. Grieb, an incumbent Class I director, informed the Board of her decision to retire from the Board effective at the 2025 annual meeting of stockholders and as a result to not seek to stand for re-election at the 2025 meeting.
Departed

Thomas E. Henning

Director
FIBK · FIRST INTERSTATE BANCSYSTEM INC
Filed
March 19, 2025, 7:59 PM ET
Mr. Thomas E. Henning, having reached the retirement age of 72 on March 14, 2025, resigned from the registrant’s Board of Directors (the “Board”), with such resignation to become effective as of the registrant’s 2025 annual meeting of stockholders as provided in the guidelines.
Departed

David Novak

Director
CMCSA · COMCAST CORP
Filed
March 19, 2025, 7:59 PM ET
At such time, Mr. Novak will vacate his current position on Comcast’s Board of Directors.
Departed

Masiar Tayebi

Executive Vice President, Chief Strategy and Information Officer
SpartanNash Co
Effective
2025-04-11
Filed
March 19, 2025, 7:59 PM ET
On March 13, 2025, it was determined that Masiar Tayebi, Executive Vice President, Chief Strategy and Information Officer of SpartanNash Company (the "Company"), will be leaving the Company, effective April 11, 2025.
Departed

Melody Harris

Chief Operations Officer and President, Oncology Data Solutions
NEO · NEOGENOMICS INC
Effective
2025-04-01
Filed
March 19, 2025, 7:59 PM ET
Additionally, on March 18, 2025, the Company announced that the Chief Operations Officer and President, Oncology Data Solutions position is being eliminated and as a result, Melody Harris, the current Chief Operations Officer and President, Oncology Data Solutions will no longer hold such role effective April 1, 2025.
Departed

Ileana Stone

Chief Compliance Officer
Lafayette Square USA, Inc.
Effective
2025-03-14
Successor
Joyce Martineau
Filed
March 19, 2025, 7:59 PM ET
Effective March 14, 2025, Ileana Stone will no longer serve as Chief Compliance Officer of Lafayette Square USA, Inc. (the “Company”).
Departed

William Restrepo

Chief Financial Officer
NBR · NABORS INDUSTRIES LTD
Effective
2025-09-30
Successor
Miguel Rodriguez
Filed
March 19, 2025, 7:59 PM ET
William Restrepo, the Company’s Chief Financial Officer, will transition from his role and retire as Chief Financial Officer on September 30, 2025.
Departed

James J. Henson

President
LFT · Lument Finance Trust, Inc.
Effective
2025-05-01
Successor
Greg D. Calvert
Filed
March 19, 2025, 7:59 PM ET
On March 18, 2025, Mr. James J. Henson notified the Board of Directors (the “Board”) of the Company of his intention to resign as President of the Company, effective as of May 1, 2025.
Departed

Kim Scott

President and Chief Executive Officer
VSTS · Vestis Corp
Effective
2025-03-18
Successor
Phillip Holloman
Filed
March 19, 2025, 7:59 PM ET
On March 18, 2025, the Board of Directors of Vestis Corporation (the “Company” or “Vestis”) determined that Kim Scott, President and Chief Executive Officer, will leave her positions with the Company, effective March 18, 2025.
Departed

Ruey-Bin Kao

Director
IROBOT CORP
Filed
March 19, 2025, 7:59 PM ET
On March 18, 2025, Dr. Ruey-Bin Kao informed the Board of Directors (the “Board”) of iRobot Corporation (the “Company”) that he will not stand for re-election to the Board when his term expires at the Company’s upcoming 2025 annual meeting of stockholders.
Departed

Bala S. Manian

director
VCNX · VACCINEX, INC.
Effective
2025-03-18
Filed
March 19, 2025, 7:59 PM ET
On March 18, 2025, Bala S. Manian informed Vaccinex, Inc. (the “Company”) of his resignation as a director of the Company effective immediately.
Departed

Shuai Li

Director
LSH · Lakeside Holding Ltd
Effective
2025-03-14
Filed
March 19, 2025, 7:59 PM ET
Mr. Shuai Li resigned from his position as a member of the Board, effective March 14 , 2025.
Departed

Samuel Sayegh

director
USAR · USA Rare Earth, Inc.
Effective
2025-03-13
Filed
March 19, 2025, 7:59 PM ET
At the Effective Time of the Merger, each of Paula Sutter, Nicholas Shekerdemian, Erica Dorfman, Eliot Richmond and Samuel Sayegh resigned as directors of IPXX with immediate effect.
Departed

Peter Ondishin

Chief Financial Officer
USAR · USA Rare Earth, Inc.
Effective
2025-03-13
Filed
March 19, 2025, 7:59 PM ET
At the Effective Time of the Merger, each of Michael Blitzer and Peter Ondishin resigned from their roles as Chief Executive Officer and Chief Financial Officer, respectively.
Departed

Eliot Richmond

director
USAR · USA Rare Earth, Inc.
Effective
2025-03-13
Filed
March 19, 2025, 7:59 PM ET
At the Effective Time of the Merger, each of Paula Sutter, Nicholas Shekerdemian, Erica Dorfman, Eliot Richmond and Samuel Sayegh resigned as directors of IPXX with immediate effect.
Departed

Erica Dorfman

director
USAR · USA Rare Earth, Inc.
Effective
2025-03-13
Filed
March 19, 2025, 7:59 PM ET
At the Effective Time of the Merger, each of Paula Sutter, Nicholas Shekerdemian, Erica Dorfman, Eliot Richmond and Samuel Sayegh resigned as directors of IPXX with immediate effect.
Departed

Michael Blitzer

Chief Executive Officer
USAR · USA Rare Earth, Inc.
Effective
2025-03-13
Successor
Joshua Ballard
Filed
March 19, 2025, 7:59 PM ET
At the Effective Time of the Merger, each of Michael Blitzer and Peter Ondishin resigned from their roles as Chief Executive Officer and Chief Financial Officer, respectively.
Departed

Nicholas Shekerdemian

director
USAR · USA Rare Earth, Inc.
Effective
2025-03-13
Filed
March 19, 2025, 7:59 PM ET
At the Effective Time of the Merger, each of Paula Sutter, Nicholas Shekerdemian, Erica Dorfman, Eliot Richmond and Samuel Sayegh resigned as directors of IPXX with immediate effect.
Departed

Paula Sutter

director
USAR · USA Rare Earth, Inc.
Effective
2025-03-13
Filed
March 19, 2025, 7:59 PM ET
At the Effective Time of the Merger, each of Paula Sutter, Nicholas Shekerdemian, Erica Dorfman, Eliot Richmond and Samuel Sayegh resigned as directors of IPXX with immediate effect.
Departed

Richard A. Costello

Chief Financial Officer and Principal Accounting Officer
GRBK · Green Brick Partners, Inc.
Effective
2025-03-17
Successor
Jeffery Cox
Filed
March 19, 2025, 7:59 PM ET
On March 17, 2025, Mr. Richard A. Costello, who has served since 2014 as the Chief Financial Officer and Principal Accounting Officer of Green Brick Partners, Inc. (the “Company”), resigned from his position effective March 17, 2025
Departed

Jon N Leonard

President, Secretary and Director
ARtelligence Holdings, Inc.
Effective
2025-03-19
Filed
March 19, 2025, 7:59 PM ET
I, Jon N Leonard (Dr. Jon), as a Member of the Board of Directors of ARtelligence Holdings Inc. (“the Company”) and as President and Secretary of the Company, do hereby resign from the Board and from my positions in the Company and from all duties thereto, effective immediately.
Departed

Celeste Fralick

director
AWHL · Aspira Women's Health Inc.
Effective
2025-03-31
Filed
March 19, 2025, 7:59 PM ET
On March 15, 2025, Celeste Fralick informed the Board of Directors of Aspira Women’s Health Inc. (the “Company”) that she was resigning as a director of the Company, for personal reasons, effective March 31, 2025.
Departed

Alan Day

President
NGLD · Nevada Canyon Gold Corp.
Effective
2025-03-18
Successor
Lisa Doddridge
Filed
March 19, 2025, 7:59 PM ET
Mr. Day resigned as President on March 18, 2025
Departed

James Holm

Chief Financial Officer
CRON · Cronos Group Inc.
Effective
2025-03-19
Successor
Anna Shlimak
Filed
March 19, 2025, 7:59 PM ET
As of the Effective Date, James Holm will no longer serve as the Company’s Chief Financial Officer.
Departed

John P. Jumper

Director
HBB · Hamilton Beach Brands Holding Co
Effective
2025-05-08
Filed
March 19, 2025, 7:59 PM ET
On March 18, 2025, John P. Jumper informed the Board of Directors (the “Board”) of Hamilton Beach Brands Holding Company (the “Company”) that he will not stand for re-election as a director at the Company’s Annual Meeting of Stockholders expected to be held on or around May 8, 2025.
Departed

Sam Sang-Koo Shim

Director
MCBS · MetroCity Bankshares, Inc.
Effective
2025-05-31
Filed
March 19, 2025, 7:59 PM ET
On March 19, 2025, Sam Sang-Koo Shim notified MetroCity Bankshares, Inc. (the “Company”) and Metro City Bank, the wholly owned banking subsidiary of the Company (the “Bank”), of his decision to resign as a member of the Board of Directors (the “Board”) of the Company and the Bank, effective as of May 31, 2025.
Departed

Cody Gallarda

Executive Vice President, Chief Financial Officer, and Treasurer
SLND · Southland Holdings, Inc.
Effective
2025-03-28
Successor
Keith Bassano
Filed
March 19, 2025, 7:59 PM ET
Cody Gallarda notified the Company of his decision to resign as Executive Vice President, Chief Financial Officer, and Treasurer of Southland Holdings, Inc.
Departed (interim)

Julie R. Markwood

Chief Accounting Officer
BHRB · Burke & Herbert Financial Services Corp.
Effective
2025-04-02
Successor
Kirtan Parikh
Filed
March 19, 2025, 7:59 PM ET
Accordingly, and with deep regret, Ms. Markwood’s employment will cease effective April 2, 2025.
Departed

J. Phillip Holloman

Director
PHM · PULTEGROUP INC/MI/
Effective
2025-04-30
Filed
March 18, 2025, 7:59 PM ET
On March 13, 2025, J. Phillip Holloman, a member of the Board of Directors (the “Board”) of PulteGroup, Inc. (the “Company”), informed the Board of his decision to not stand for re-election at the end of his current term at the Company’s 2025 annual meeting of shareholders scheduled to be held on April 30, 2025
Departed

Frederick Herbst

Director
LIEN · Chicago Atlantic BDC, Inc.
Effective
2025-03-13
Successor
Supurna VedBrat
Filed
March 18, 2025, 7:59 PM ET
On March 13, 2025, each of Mr. Frederick Herbst and Mr. Jason Papastavrou resigned from his position as Director of the Company.
Departed

Jason Papastavrou

Director
LIEN · Chicago Atlantic BDC, Inc.
Effective
2025-03-13
Successor
Patrick McCauley
Filed
March 18, 2025, 7:59 PM ET
On March 13, 2025, each of Mr. Frederick Herbst and Mr. Jason Papastavrou resigned from his position as Director of the Company.
Departed

Andreas Bodmeier

Chief Executive Officer
LIEN · Chicago Atlantic BDC, Inc.
Effective
2025-03-13
Successor
Peter Sack
Filed
March 18, 2025, 7:59 PM ET
On March 13, 2025, Mr. Andreas Bodmeier resigned from his position as Chief Executive Officer of the Company.
Departed

Patrick Williams

Chief Financial Officer
STAA · STAAR SURGICAL CO
Effective
2025-03-17
Successor
Deborah Andrews
Filed
March 18, 2025, 7:59 PM ET
Patrick Williams has agreed to step down, effective as of the same date, at the request of the Board from his position as Chief Financial Officer.
Departed

Keith Holliday

Chief Technology Officer
STAA · STAAR SURGICAL CO
Effective
2025-03-17
Filed
March 18, 2025, 7:59 PM ET
Keith Holliday, PhD has agreed to retire, effective as of the Effective Date, at the request of the Board from his position as Chief Technology Officer
Departed

Edward Kaye

Chief Executive Officer
STOK · Stoke Therapeutics, Inc.
Effective
2025-03-19
Successor
Ian F. Smith
Filed
March 18, 2025, 7:59 PM ET
On March 16, 2025, Dr. Edward Kaye, M.D., 75, the Company’s Chief Executive Officer (“CEO”) and a director, informed the Company’s Board of Directors (the “Board”) of his intention to step down from his position as the Company’s CEO, effective March 19, 2025 (the “Transition Date”).
Departed

Ken Kobayashi

Chief Medical Officer
PYXS · Pyxis Oncology, Inc.
Effective
2025-03-18
Successor
Lara S. Sullivan
Filed
March 18, 2025, 7:59 PM ET
On March 18, 2025, the Company announced that Ken Kobayashi, M.D., F.A.C.P, is stepping down from his position as the Company's Chief Medical Officer.
Departed

Michael Crawford

President, Chief Executive Officer, and Chairman of the Board of Directors
Hall of Fame Resort & Entertainment Co
Effective
2025-05-18
Filed
March 18, 2025, 7:59 PM ET
On March 12, 2025, Michael Crawford informed the Board of Directors of Hall of Fame Resort & Entertainment Company (the “Company”) that he intends to resign as President, Chief Executive Officer, and Chairman of the Board of Directors.
Departed

Thomas E. Haas

Senior Vice President and Chief Accounting Officer
GDEN · NEW ROYAL HOLDCO I INC.
Effective
2025-03-21
Successor
Viktoryia G. Pulliam
Filed
March 18, 2025, 7:59 PM ET
On March 14, 2025, Mr. Thomas E. Haas, age 64, who has served as Golden Entertainment, Inc.’s (the “Company”) Senior Vice President and Chief Accounting Officer since March 2020, informed the Company of his decision to retire effective March 21, 2025 (the “Transition Date”).
Departed

Melody Harris

Chief Operations Officer
NEO · NEOGENOMICS INC
Effective
2025-04-01
Filed
March 18, 2025, 7:59 PM ET
Additionally, on March 18, 2024, the Company announced that the Chief Operations Officer position is being eliminated and as a result, Melody Harris, the current Chief Operations Officer, will no longer hold such role and will no longer be a named executive officer effective April 1, 2025.
Departed

Sharon R. Barner

Chief Administrative Officer
CMI · CUMMINS INC
Effective
2025-05-31
Filed
March 18, 2025, 7:59 PM ET
On March 18, 2025, Cummins Inc. (the “Company”) issued a press release announcing that Sharon R. Barner, the Company’s Chief Administrative Officer, will retire from the Company, effective May 31, 2025.
Departed

E. Forrest Jones, Jr.

Director
METC · Ramaco Resources, Inc.
Effective
2025-03-14
Successor
Evan H. Jenkins
Filed
March 18, 2025, 7:59 PM ET
E. Forrest Jones, Jr. resigned from the Board of Directors (the “Board”) and from his positions on all committees of the Board effective March 14, 2025.
Departed

Gina Chapman

President and Chief Executive Officer
CARGO Therapeutics, Inc.
Effective
2025-05-19
Successor
Anup Radhakrishnan
Filed
March 18, 2025, 7:59 PM ET
Gina Chapman, the Company’s President, CEO and member of the board of directors will be leaving the Company effective May 19, 2025.
Departed

Ginna Laport

Chief Medical Officer
CARGO Therapeutics, Inc.
Effective
2025-05-19
Filed
March 18, 2025, 7:59 PM ET
Dr. Ginna Laport, the Company’s Chief Medical Officer ("CMO"), will be leaving the Company effective May 19, 2025.
Departed

Eric K. Brandt

Director
MAC · MACERICH CO
Filed
March 18, 2025, 7:59 PM ET
On March 12, 2025, Eric K. Brandt advised the Board of Directors (the “Board”) of The Macerich Company (the “Company”) that he will not stand for re-election as a director of the Company at the 2025 annual meeting of stockholders (the “2025 Annual Meeting”).
Departed

Jaynie Studenmund

Director
EXLS · ExlService Holdings, Inc.
Filed
March 18, 2025, 7:59 PM ET
On March 12, 2025, Jaynie Studenmund, a member of the Board of Directors (the “Board”) of ExlService Holdings, Inc. (the “Company”), notified the Board that she has decided not to stand for re-election at the Company’s 2025 annual meeting of stockholders (the “Annual Meeting”), at which time she will resign from the Board and the committees on which she currently serves.
Departed

Derek Adams

Director
KLRS · Kalaris Therapeutics, Inc.
Effective
2025-03-18
Filed
March 18, 2025, 7:59 PM ET
at the Effective Time, Vikas Sinha, Derek Adams, Ph.D., Malcom Brenner, M.D., Ph.D., Jeffrey S. Bornstein, Shawn Tomasello and Juan Vera, M.D., resigned from the Board
Departed

Vikas Sinha

Director
KLRS · Kalaris Therapeutics, Inc.
Effective
2025-03-18
Filed
March 18, 2025, 7:59 PM ET
at the Effective Time, Vikas Sinha, Derek Adams, Ph.D., Malcom Brenner, M.D., Ph.D., Jeffrey S. Bornstein, Shawn Tomasello and Juan Vera, M.D., resigned from the Board
Departed

Juan Vera

Director
KLRS · Kalaris Therapeutics, Inc.
Effective
2025-03-18
Filed
March 18, 2025, 7:59 PM ET
at the Effective Time, Vikas Sinha, Derek Adams, Ph.D., Malcom Brenner, M.D., Ph.D., Jeffrey S. Bornstein, Shawn Tomasello and Juan Vera, M.D., resigned from the Board

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.